Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 4Recurrence 2Colorectal Neoplasms 2Breast Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Nodule 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Postoperative Complications 1Pneumonia 1Papillomavirus Infections 1Pancreatic Neoplasms 1Osteosarcoma 1Obesity 1Neoplasms, Plasma Cell 1Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell 1Lung Neoplasms 1Lung Diseases, Interstitial 1Locally Advanced Breast Cancer 1Intermittent Fasting 1Hypothyroidism 1Hyperthyroidism 1Hepatitis 1

Interventions

Sorafenib 131lenvatinib 115Bevacizumab 88Radiosurgery 69atezolizumab 55sintilimab 54Nivolumab 51durvalumab 43Hepatectomy 43Fluorouracil 42apatinib 41Oxaliplatin 41camrelizumab 38Radiofrequency Ablation 38pembrolizumab 36Radiotherapy 36tislelizumab 35Leucovorin 31Magnetic Resonance Spectroscopy 30Immune Checkpoint Inhibitors 29Doxorubicin 28Folfox protocol 26tremelimumab 25regorafenib 25Cisplatin 20spartalizumab 19donafenib 19Gemcitabine 19Cyclophosphamide 19toripalimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Hepatocellular × Clinical Protocols × Clear all
NCT05429190 2023-11-29

Validation of SMS Protocol for HCC Screening in High-risk Patients

Erasmus Medical Center

Unknown
470 enrolled
Gastrointestinal

Fibrosis, Hepatitis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡